SciELO - Scientific Electronic Library Online

vol.38 número4Interrupciones de embarazo por causa genéticaResultados maternos-perinatales de pacientes con preeclampsia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados




  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO


Revista Cubana de Obstetricia y Ginecología

versión impresa ISSN 0138-600X


FIGUEROA CALDERON, Isabel; SAAVEDRA MOREDO, Daymí; DE LA TORRES SIERES, Yudith  y  SANCHEZ LUEIRO, Mayra. Effectiveness of magnesium sulfate in pre-eclampsia treatment. Rev Cubana Obstet Ginecol [online]. 2012, vol.38, n.4, pp.458-466. ISSN 0138-600X.

Introduction: eclampsia is a disease of human pregnancy, responsible for a significant increase in the rates of maternal and perinatal morbidity and mortality. Objective: to study the effectiveness of the use of magnesium sulfate in the treatment of pre-eclampsia. Methods: an intervention and evaluation study in health services was conducted from June 1st to December 31st, 2011. 98 pregnant women admitted to the Perinatal Care unit were the universe and sample of this study. They had been classified as pre-eclamptic. Results: 68.36 % of these women were 20-34 years old, 75.51 % were nulliparous. 2.04 % had oligoanuria as response to the drug. 100 % of these patients used hypotensive drugs and hydralazine was mostly used (63.25 %). More than 50 % delivered at the end of pregnancy with healthy weight of the product. 76.50 % of births occurred by cesarean. The most common maternal complication was hypertension, and neonatal depression at birth was present in 7.14 %. Conclusions: magnesium sulfate treatment was effective because it was able to reduce the number of pregnant women with eclampsia, when using prophylactically.

Palabras clave : magnesium sulfate; eclampsia and pre-eclampsia.

        · resumen en Español     · texto en Español     · Español ( pdf )